VOOZH about

URL: https://pubmed.ncbi.nlm.nih.gov/32371096/

⇱ SARS-CoV-2 was already spreading in France in late December 2019 - PubMed


Clipboard, Search History, and several other advanced features are temporarily unavailable.
Skip to main page content
👁 Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

👁 Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Abstract

The COVID-19 epidemic is believed to have started in late January 2020 in France. Here we report a case of a patient hospitalised in December 2019 in an intensive care unit in a hospital in the north of Paris for haemoptysis with no aetiological diagnosis. RT-PCR was performed retrospectively on the stored respiratory sample and confirmed the diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Based on this result, it appears that the COVID-19 epidemic started much earlier in France.

Keywords: COVID-19; Coronavirus disease 2019; France; Intensive care unit; SARS-CoV-2.

PubMed Disclaimer

Figures

👁 Fig 1
Fig. 1
Selection process for testing. COVID-19, coronavirus 2019; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
👁 Fig 2
Fig. 2
Result of Charité protocol RT-PCR assay : patient's curve in yellow; positive and negative test samples in purple.
👁 Fig 3
Fig. 3
Chest computed tomography (CT) images at baseline. Bilateral pulmonary ground-glass opacities appear in the inferior lobes.

References

    1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J. China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. doi: 10.1056/NEJMoa2001017. - DOI - PMC - PubMed
    1. World Health Organization (WHO). WHO Director-General's opening remarks at the media briefing on COVID-19—11 March 2020.https://www.who.int/dg/speeches/detail/who-director-general-8-opening-re...[accessed 30 April 2020].
    1. Lescure FX, Bouadma L, Nguyen D, Parisey M, Wicky PH, Behillil S. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 2020 Mar 27 doi: 10.1016/S1473-3099(20)30200-0. [Epub ahead of print] - DOI - PMC - PubMed
    1. Bernard Stoecklin S, Rolland P, Silue Y, Mailles A, Campese C, Simondon A. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. Euro Surveill. 2020:25. doi: 10.2807/1560-7917.ES.2020.25.6.2000094. - DOI - PMC - PubMed
    1. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–1720. doi: 10.1056/NEJMoa2002032. - DOI - PMC - PubMed
Cite

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.